Heikki Lanckriet

Heikki Lanckriet

Chief Executive Officer chez 4BASEBIO PLC

Fortune : 15 M $ au 31/03/2024

47 ans
Health Technology
Consumer Services
Finance

Provenance du réseau au premier degré de Heikki Lanckriet

EntitéType d'entitéIndustrie
Public Company Pharmaceuticals: Major 15
Public Company Pharmaceuticals: Major 11
Public Company Financial Conglomerates 8
7
Subsidiary Biotechnology 7
6
Subsidiary Biotechnology 6
Public Company Biotechnology 5
5
Holding Company Miscellaneous Commercial Services 5
4
Holding Company Pharmaceuticals: Major 4
3
Holding Company Pharmaceuticals: Major 3
Public Company Medical Specialties 3
1
Subsidiary Wholesale Distributors 1

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Heikki Lanckriet via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
Pharmaceuticals: Major

Hiromichi Kimura

Corporate Officer/Principal

BAYER AG Pharmaceuticals: Major

Ulrich Granzer

Heino von Prondzynski

General Counsel

Corporate Officer/Principal

Miscellaneous Commercial Services

Cristina Garmendia Mendizábal

Consultant / Advisor

MARNA BETEILIGUNGEN AG Financial Conglomerates

Hansjörg Plaggemars

Karin Lergenmüller

Director/Board Member

Director/Board Member

ALTHEADX INC Pharmaceuticals: Major

Gregory Hamilton

Andrew Lukowiak

Chief Executive Officer

Chief Operating Officer

DEUTSCHE BALATON AG Investment Banks/Brokers

Hansjörg Plaggemars

Wilhelm Konrad Zours

Alexander Link

Corporate Officer/Principal

Chairman

Director of Finance/CFO

TAKEDA PHARMACEUTICAL COMPANY LIMITED Pharmaceuticals: Major

Hiromichi Kimura

Corporate Officer/Principal

SPARTA AG Investment Managers

Wilhelm Konrad Zours

Karin Lergenmüller

Chairman

Director/Board Member

Pharmaceuticals: Major

Jürgen Christian Baumann

Director/Board Member

Universität zu Köln College/University

Hermann Lübbert

Helge Lubenow

Doctorate Degree

Doctorate Degree

Miscellaneous Commercial Services

Hermann Lübbert

María del Pilar de la Huerta Martínez

Chief Executive Officer

Chief Executive Officer

Ruhr-Universität Bochum College/University

Hermann Lübbert

Franca Ruhwedel

Corporate Officer/Principal

Doctorate Degree

ASTELLAS PHARMA INC. Pharmaceuticals: Major

Hiromichi Kimura

Corporate Officer/Principal

Internet Software/Services

Ludwig Lutter

Director of Finance/CFO

Hospital/Nursing Management

Hiromichi Kimura

Corporate Officer/Principal

University of Münster College/University

Heino von Prondzynski

Franca Ruhwedel

Undergraduate Degree

Undergraduate Degree

Eberhard Karls Universität Tübingen College/University

Ulrich Granzer

Jörgen Thielmann

Doctorate Degree

Graduate Degree

Universidad Complutense de Madrid College/University

María del Pilar de la Huerta Martínez

Undergraduate Degree

Pharmaceuticals: Major

Jürgen Christian Baumann

Corporate Officer/Principal

University of Tokyo College/University

Hiromichi Kimura

Doctorate Degree

HEIDELBERGER BETEILIGUNGSHOLDING AG Financial Conglomerates

Hansjörg Plaggemars

Karin Lergenmüller

Corporate Officer/Principal

Director/Board Member

The University of Hull College/University

Trevor Jarman

Doctorate Degree

Financial Conglomerates

Hansjörg Plaggemars

Wilhelm Konrad Zours

Karin Lergenmüller

Director/Board Member

Corporate Officer/Principal

Chairman

Investment Managers

Pietro Puglisi

Marta Antonucci

Private Equity Analyst

Private Equity Investor

University of Seville College/University

Cristina Garmendia Mendizábal

Undergraduate Degree

Investment Managers

Trevor Jarman

Private Equity Investor

Miscellaneous Commercial Services

María del Pilar de la Huerta Martínez

Chief Executive Officer

Miscellaneous Commercial Services

Cristina Garmendia Mendizábal

Director/Board Member

Biotechnology

Peter Llewellyn-Davies

Ulrich Granzer

Chief Executive Officer

Director/Board Member

Engineering & Construction

Hansjörg Plaggemars

Wilhelm Konrad Zours

Corporate Officer/Principal

Chairman

Biotechnology

María del Pilar de la Huerta Martínez

Director/Board Member

Persavita Ltd.

Trevor Jarman

Chairman

Pharmaceuticals: Major

María del Pilar de la Huerta Martínez

Chief Executive Officer

Natures Remedies Ltd.

Trevor Jarman

Chief Executive Officer

Cambridge Cell Networks Ltd.

Trevor Jarman

Director/Board Member

Swangap Flat Management Led

Trevor Jarman

Director/Board Member

Alpha Cleantec AG

Hansjörg Plaggemars

Karin Lergenmüller

Corporate Officer/Principal

Chairman

Financial Conglomerates

Hansjörg Plaggemars

Alexander Link

Chairman

Director/Board Member

Protus Ltd.

Trevor Jarman

Director/Board Member

Miscellaneous Commercial Services

Hiromichi Kimura

Director/Board Member

Fundación UNICEF - Comité Español Investment Trusts/Mutual Funds

Cristina Garmendia Mendizábal

Corporate Officer/Principal

BIOTECHNOLOGY ASSETS, S.A. Biotechnology

María del Pilar de la Huerta Martínez

Chief Executive Officer

Investment Managers

Laura Iris Ferro

Pietro Puglisi

Private Equity Investor

Founder

Epidesease SL

María del Pilar de la Huerta Martínez

Director/Board Member

Cb4living LLP

Trevor Jarman

Corporate Officer/Principal

Biotechnology

Cristina Garmendia Mendizábal

María del Pilar de la Huerta Martínez

Founder

Chief Executive Officer

Packaged Software

Hansjörg Plaggemars

Alexander Link

Director/Board Member

Director/Board Member

Statistiques

Internationale

Allemagne 19
Espagne 13
Royaume-Uni 10
Japon 5
Etats-Unis 4

Sectorielle

Health Technology 15
Finance 10
Consumer Services 9
Commercial Services 7
Technology Services 3

Opérationnelle

Director/Board Member 234
Corporate Officer/Principal 82
Chairman 60
Chief Executive Officer 50
Independent Dir/Board Member 33
  1. Bourse
  2. Insiders
  3. Heikki Lanckriet
  4. Connexions Sociétés